EU Oncology Biosimilars

Infographic

October 26, 2018
EU Oncology Biosimilars

IQVIA research identified that the total EU5 oncology market grew to $25 bn in 2017, and the launch of biosimilars over the next few years will make new drugs more accessible to patients. The information is for EU5 countries (France, Germany, Italy, Spain and U.K.).